The Oncosearch | Oncotarget

G-quadruplex landscape and its regulation revealed by a new antibody capture method Research Paper

Subhamoy Datta, Manthan Patel, Chakkarai Sathyaseelan, Chandrama Ghosh, Akanksha Mudgal, Divyesh Patel, Thenmalarchelvi Rathinavelan, Umashankar Singh

Published Feb 21, 2024 · Vol. 15, No. 1 · pp. 175-198

Keywords: DNA G-quadruplexes, G4-ChIP, CGGBP1, CTCF, G/C-skew

Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy Retraction

Changhwan Yoon, Kevin K. Chang, Jun Ho Lee, William D. Tap, Charles P. Hart, M. Celeste Simon, Sam S. Yoon

Published Feb 8, 2024 · Vol. 15, No. 1 · pp. 123-123

Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas Research Paper

Thomas M. Cardillo, Maria B. Zalath, Roberto Arrojo, Robert M. Sharkey, Serengulam V. Govindan, Chien-Hsing Chang, David M. Goldenberg

Published Jan 30, 2024 · Vol. 15, No. 1 · pp. 144-158

Keywords: sacituzumab govitecan, Trop-2, SN-38, carboplatin, cisplatin

GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells Research Paper

Laurence Booth, Jane L. Roberts, Cameron West, Paul Dent

Published Jan 29, 2024 · Vol. 15, No. 1 · pp. 159-174

Keywords: autophagy, ER stress, GZ17-6.02, bortezomib, proteasome inhibitor

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

Michael R. Booth, Laurence Booth, Jane L. Roberts, Cameron West, Paul Dent

Published Jan 29, 2024 · Vol. 15, No. 1 · pp. 124-133

Keywords: autophagy, ER stress, GZ17-6.02, bexarotene, vorinostat

Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland Research Paper

Wei Zhang, Arndt A. Schmitz, Roosa E. Kallionpää, Merja Perälä, Niina Pitkänen, Mikko Tukiainen, Erika Alanne, Korinna Jöhrens, Renate Schulze-Rath, Bahman Farahmand, Jihong Zong

Published Jan 12, 2024 · Vol. 15, No. 1 · pp. 106-116

Keywords: NTRK gene fusion, papillary thyroid cancer, clinicogenomic, epidemiology, biobank

Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples Research Paper

Chongtham Sovachandra Singh, Nabamita Boruah, Atanu Banerjee, Sillarine Kurkalang, Pooja Swargiary, Hughbert Dakhar, Anupam Chatterjee

Published Jan 11, 2024 · Vol. 15, No. 1 · pp. 76-89

Keywords: Mad2 gene, histone methylation, histone acetylation, Rb-phosphorylation, esophageal cancer

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo

Published Jan 10, 2024 · Vol. 15, No. 1 · pp. 49-64

Keywords: brain tumor, diffuse glioma, oligodendroglioma, glioblastoma, BCAS1

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Alberto Moscona-Nissan, Karl J. Habashy, Victor A. Arrieta, Adam M. Sonabend, Crismita Dmello

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 117-122

Keywords: glioblastoma, predictive biomarker, CRISPR screen, paclitaxel

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Ashley Del Dosso, Elizabeth Tadevosyan, James R. Berenson

Published Dec 23, 2023 · Vol. 15, No. 1 · pp. 65-75

Keywords: multiple myeloma, ruxolitinib, JAK/STAT, cytokine, clinical trial

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

Mark Lee, Luc GT Morris

Published Dec 15, 2023 · Vol. 15, No. 1 · pp. 36-48

Keywords: thyroid cancer, drug resistance, anaplastic transformation, BRAF inhibitors, PIK3CA

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Fusheng Zhou, Lili Tang, Siyuan Le, Mei Ge, Dragan Cicic, Fubo Xie, Jinmin Ren, Jiong Lan, Qiang Lu

Published Dec 9, 2023 · Vol. 14, No. 1 · pp. 997-1008

Keywords: GFH009, CDK9, cancer, leukemia, cell cycle

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Yong Teng

Published Dec 7, 2023 · Vol. 14, No. 1 · pp. 995-996

Keywords: cancer stem cells; exosomes, the tumor microenvironment, therapeutic target, anticancer strategy

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Gulimirerouzi Fnu, Georg F. Weber

Published Nov 24, 2023 · Vol. 14, No. 1 · pp. 957-969

Keywords: metastasis, metabolism, anchorage independence, mitochondrial mass, peroxide

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan

Published Nov 21, 2023 · Vol. 15, No. 1 · pp. 104-105

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Mallika Tripathy, Amy Bui, Jared Henderson, Jeffrey Sun, Christian Rutan Woods, Soumya Somani, Thao Doan, Anto Sam Crosslee Louis Sam Titus, Chandra Mohan

Published Oct 26, 2023 · Vol. 14, No. 1 · pp. 910-918

Keywords: FAAH, breast cancer, cancer therapy, apoptosis

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Recep Bayraktar, Martin Pichler, Pinar Kanlikilicer, Cristina Ivan, Emine Bayraktar, Nermin Kahraman, Burcu Aslan, Serpil Oguztuzun, Mustafa Ulasli, Ahmet Arslan, George Calin, Gabriel Lopez-Berestein, Bulent Ozpolat

Published Oct 26, 2023 · Vol. 14, No. 1 · pp. 908-909

Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer Correction

Yiyao Zhang, Li Liu, Pei Fan, Nathalie Bauer, Jury Gladkich, Eduard Ryschich, Alexandr V. Bazhin, Nathalia A. Giese, Oliver Strobel, Thilo Hackert, Ulf Hinz, Wolfgang Gross, Franco Fortunato, Ingrid Herr

Published Oct 4, 2023 · Vol. 15, No. 1 · pp. 504-506

GLS2 shapes ferroptosis in hepatocellular carcinoma Editorial

Sawako Suzuki, Divya Venkatesh, Tomoaki Tanaka, Carol Prives

Published Sep 30, 2023 · Vol. 14, No. 1 · pp. 900-903

Keywords: ferroptosis, hepatocellular carcinoma, GLS2, p53, tumor suppression

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro Correction

Anastasia Frank-Kamenetskii, Julia Mook, Meredith Reeves, Corinne A. Boulanger, Thomas J. Meyer, Lauren Ragle, H. Caroline Jordan, Gilbert H. Smith, Brian W. Booth

Published Sep 26, 2023 · Vol. 14, No. 1 · pp. 842-842

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

G-quadruplex landscape and its regulation revealed by a new antibody capture method Research Paper

Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy Retraction

Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas Research Paper

GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells Research Paper

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland Research Paper

Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples Research Paper

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer Correction

GLS2 shapes ferroptosis in hepatocellular carcinoma Editorial

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

G-quadruplex landscape and its regulation revealed by a new antibody capture method Research Paper

Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy Retraction

Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas Research Paper

GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells Research Paper

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells Research Paper

Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland Research Paper

Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples Research Paper

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer Correction

GLS2 shapes ferroptosis in hepatocellular carcinoma Editorial

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro Correction